AI ultrasound to predict brain pressure in lung cancer with meningitis-like spread
Part of Brain & nervous system, Cancer, Lungs & breathing clinical trials.
This study uses artificial intelligence (AI) to read ultrasound images and predict pressure inside the skull and overall outlook for people with lung cancer that has spread to the lining of the brain. If you have non-small cell lung cancer and leptomeningeal metastases, the trial aims to find better ways to monitor your condition without repeat spinal taps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have non-small cell lung cancer (NSCLC).
- The cancer has spread to the lining of your brain or spinal cord (leptomeningeal metastases).
- You have had a lumbar puncture (spinal tap) and chemotherapy given through that tap at the study center.
- You feel well enough to be out of bed at least part of the day (ECOG score 0-3).
- Your blood counts, liver, and kidney function are within safe ranges.
- You do not have a bleeding disorder, active thrombosis, or other cancer history, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose radiation to the whole brain, immunotherapy, and chemotherapy given through a lumbar puncture. It is for people with lung cancer that has spread to the lining of the brain and has not responded to standard treatments.
This study uses advanced computer models to predict how likely lung cancer is to spread to the brain and how it may affect your health. It includes people with lung cancer who are getting standard treatment and have had recent MRI and CT scans.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial tests an artificial intelligence platform that helps doctors predict if lymph nodes in the chest contain cancer during a routine ultrasound procedure. It aims to make staging more accurate for people with suspected or confirmed non-small cell lung cancer.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This trial tests whether doing scheduled brain MRI scans can lower the chance that lung cancer later causes symptomatic brain metastases (tumors that cause symptoms in the brain). If you’re eligible, you’ll get brain MRI surveillance at a specific time after starting radiation.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.